$EPZM - On our trading list with news today and analyst comments. Epizyme received FDA approval for TAZVERIK (Taz).Jefferies sees broad approval for Epizyme's Taz as 'fundamental positive'Jefferies analyst Michael Yee maintained a Buy rating and $35 price target on Epizyme following the company obtaining a broad approval for Taz in the treatment of relapsed/refractory follicular lymphoma, which the analyst feels is a "fundamental positive" and an "important de-risking event to confirm an official label indication that could address a $500M to $1B long-term opportunity." Yee added that this could increase M&A potential for Epizyme. $EPZM, Epizyme, Inc. / H1 Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal. If you liked this article, please click the LIKE (thumbs up) button. Feel free to leave any comments, question, or opinions. (Sign-up if you haven't already done so). Follow us/bookmark us and check back occasionally for additional articles or comments on our page... Wild Tiger Trading - start/main page. .Are you interested in trading stocks to supplement your income or make a living? Maybe become a professional trader? Many traders have the skills and nerves to trade, but not the upfront capital. Well now that problem is solved!Try2BeFunded has expanded its trading program! If you're a novice or experienced trader, you can earn access to a trading account with up to $100,000! To learn more about how to qualify, click HERE and give it a shot! You have nothing to lose it is free to try. Trade Try2BeFunded today! .